Diabetes May Short Circuit Pembrolizumab Benefits in NSCLC ...Middle East

Medscape - News
The new study shows a correlation between diabetes and poor outcomes for patients with metastatic non–small cell lung cancer (NSCLC) who received pembrolizumab. Medscape Medical News

Hence then, the article about diabetes may short circuit pembrolizumab benefits in nsclc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Diabetes May Short Circuit Pembrolizumab Benefits in NSCLC )

Apple Storegoogle play

Last updated :

Also on site :